SAN DIEGO--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO) member of Blood Centers of America (BCA), today announced that it has been selected ...

Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies.

MIAMI--(BUSINESS WIRE)--OrganaBio, LLC ("OrganaBio"), a manufacturer of GMP cells and blood products and provider of cell isolation and cryopreservation services, has acquired substantially all of the ...

ANN ARBOR, Mich., Aug. 6, 2025 /PRNewswire/ -- Excellos, Lonza, and Akadeum Life Sciences today announce a new project aimed at redefining standards for cell therapy manufacturing by elevating the ...

Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank SAN DIEGO, January 25, 2022--(BUSINESS WIRE)--Excellos, Incorporated, a cell therapy ...

SAN DIEGO — Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced it had taken additional investment to accelerate commercialization efforts. As ...

OrganaBio launches time-sensitive PBMC isolation in San Diego, extending rapid clinical sample processing to one of the ...

Excellos is the first decentralized manufacturing unit (DMU) within the nationwide network of Blood Centers of America to be selected for Good Manufacturing Compliant (GMP) manufacturing for Galapagos ...

Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank Excellos, Incorporated, a cell therapy Contract Development and Manufacturing ...